Premium
X4 Pharmaceuticals Inc (XFOR)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Morgan Stanley Investment Management Inc. | Institution | 9 442 785 | 10,01% | US$ 37,68M | 2026-03-31 |
| Empery Asset Management, LP | Institution | 8 944 118 | 9,48% | US$ 35,69M | 2026-03-31 |
| FMR LLC | Institution | 8 103 400 | 8,59% | US$ 32,33M | 2026-03-31 |
| Bain Capital Life Sciences Investors, LLC | Institution | 7 967 454 | 8,45% | US$ 31,79M | 2026-03-31 |
| Perceptive Advisors LLC | Institution | 6 737 648 | 7,14% | US$ 26,88M | 2026-03-31 |
| Perceptive Life Sciences Master Fund, Ltd. | Institution | 6 737 648 | 7,14% | US$ 26,88M | 2026-03-31 |
| Saturn V Capital Management LP | Institution | 6 456 646 | 6,85% | US$ 25,76M | 2026-03-31 |
| Deep Track Capital, LP | Institution | 6 339 535 | 6,72% | US$ 25,29M | 2026-03-31 |
| Kalehua Capital Management LLC | Institution | 3 722 840 | 3,95% | US$ 14,85M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 3 497 612 | 3,71% | US$ 13,96M | 2026-03-31 |
| Braidwell LP | Institution | 3 272 954 | 3,47% | US$ 13,06M | 2026-03-31 |
| NEA 18 Venture Growth Equity, L.P. | Institution | 3 233 744 | 3,43% | US$ 12,90M | 2025-10-27 |
| New Enterprise Associates, Inc. | Institution | 3 233 743 | 3,43% | US$ 12,90M | 2026-03-31 |
| Rosalind Advisors, Inc. | Institution | 3 214 766 | 3,41% | US$ 12,83M | 2026-03-31 |
| Blackstone Alternative Asset Management L.P. | Institution | 2 681 922 | 2,84% | US$ 10,70M | 2026-03-31 |
| Trails Edge Capital Partners, LP | Institution | 2 571 478 | 2,73% | US$ 10,26M | 2026-03-31 |
| Nantahala Capital Management, LLC | Institution | 2 449 468 | 2,60% | US$ 9,77M | 2026-03-31 |
| BVF Partners L.P. | Institution | 2 233 742 | 2,37% | US$ 8,91M | 2026-03-31 |
| Samsara BioCapital LLC | Institution | 1 832 566 | 1,94% | US$ 7,31M | 2026-03-31 |
| BlackRock, Inc. | Institution | 1 211 794 | 1,28% | US$ 4,84M | 2026-03-31 |
| Millennium Management LLC | Institution | 1 210 514 | 1,28% | US$ 4,83M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 1 158 732 | 1,23% | US$ 4,62M | 2025-08-20 |
| Woodline Partners LP | Institution | 1 001 095 | 1,06% | US$ 3,99M | 2026-03-31 |
| Susquehanna International Group, LLP | Institution | 958 821 | 1,02% | US$ 3,83M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 939 726 | 1,00% | US$ 3,75M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 906 855 | 0,96% | US$ 3,62M | 2025-08-20 |
| The Goldman Sachs Group, Inc. | Institution | 882 134 | 0,94% | US$ 3,52M | 2026-03-31 |
| Dr. Christophe Arbet-Engels | Initiés | 864 207 | 0,92% | US$ 3,45M | 2025-02-12 |
| StemPoint Capital LP | Institution | 850 742 | 0,90% | US$ 3,39M | 2026-03-31 |
| Bain Capital Life Sciences Fund II, L.P. | Institution | 607 832 | 0,64% | US$ 2,43M | 2025-12-31 |
| Dr. Mary DiBiase | Initiés | 490 980 | 0,52% | US$ 1,96M | 2025-02-12 |
| Vanguard Fiduciary Trust Company | Institution | 480 733 | 0,51% | US$ 1,92M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 403 534 | 0,43% | US$ 1,61M | 2026-03-31 |
| Dr. Arthur Taveras | Initiés | 388 026 | 0,41% | US$ 1,55M | 2024-10-07 |
| Marshall Wace LLP | Institution | 336 834 | 0,36% | US$ 1,34M | 2026-03-31 |
| Stonepine Capital Management LLC | Institution | 335 309 | 0,36% | US$ 1,34M | 2026-03-31 |
| VR Management, LLC | Institution | 330 525 | 0,35% | US$ 1,32M | 2026-03-31 |
| UBS Asset Management AG | Institution | 267 340 | 0,28% | US$ 1,07M | 2026-03-31 |
| Acorn Bioventures | Institution | 234 039 | 0,25% | US$ 933,82k | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 218 954 | 0,23% | US$ 873,63k | 2026-03-31 |
| Northern Trust Global Investments | Institution | 178 235 | 0,19% | US$ 711,16k | 2026-03-31 |
| Pale Fire Capital SE | Institution | 167 590 | 0,18% | US$ 668,68k | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
